Chenyu Mao
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 11
- Colorectal Cancer Treatments and Studies 4
- Neutropenia and Cancer Infections 3
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Nong Xu (19 shared papers)Yulong Zheng (15 shared papers)Yongfeng Ding (7 shared papers)Hongyang Yi (4 shared papers)Xiao Cheng (6 shared papers)Nong Xu (13 shared papers)Haiyong Wang (2 shared papers)Hao Wang (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)ESMO Open (3 papers)Frontiers in Oncology (3 papers)Journal of Biological Chemistry (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Chenyu Mao
47 papers receiving 623 citations
Peers
Comparison fields: 5 of 75
- Oncology 241
- Immunology 113
- Gastroenterology 27
- Cancer Research 59
- Endocrinology, Diabetes and Metabolism 56
Countries citing papers authored by Chenyu Mao
This map shows the geographic impact of Chenyu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyu Mao more than expected).
Fields of papers citing papers by Chenyu Mao
This network shows the impact of papers produced by Chenyu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyu Mao. The network helps show where Chenyu Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenyu Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 58 | |
| 2 | 2021 | 57 | |
| 3 | 2010 | 54 | |
| 4 | 2020 | 50 | |
| 5 | 2020 | 44 | |
| 6 | 2020 | 35 | |
| 7 | 1993 | 32 | |
| 8 | 2020 | 25 | |
| 9 | 2021 | 21 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 18 | |
| 12 | 2021 | 17 | |
| 13 | Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. | 1998 | 15 |
| 14 | 2022 | 11 | |
| 15 | 2019 | 11 | |
| 16 | 2022 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2022 | 10 |
About Chenyu Mao
Chenyu Mao is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 51 papers that have together received 630 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Treatments and Studies (4 papers), Ubiquitin and proteasome pathways (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Neutropenia and Cancer Infections (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Oncology (241 citations), Immunology (113 citations), Gastroenterology (27 citations), Cancer Research (59 citations) and Endocrinology, Diabetes and Metabolism (56 citations). Chenyu Mao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Nong Xu, Yulong Zheng, Yongfeng Ding, Hongyang Yi, Xiao Cheng, Nong Xu, Haiyong Wang, Hao Wang, Weizheng Liang and Chunfu Zheng. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Frontiers in Oncology, Journal of Biological Chemistry and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.